These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31896)

  • 21. Efficacy of neuroleptic medication in pervasive developmental disorders of childhood.
    Mikkelsen EJ
    Schizophr Bull; 1982; 8(2):320-32. PubMed ID: 6126001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Toxic encephalopathy caused by the combination of lithium and haloperidol].
    Destee A; Lehembre P; Petit H; Warot P
    Lille Med; 1978 Feb; 23(2):88-91. PubMed ID: 651542
    [No Abstract]   [Full Text] [Related]  

  • 23. In vivo study of the mutagenicity of biperidine, pipotiazine, chlorpromazine, and haloperidol.
    Smith M; de Souza MA; Pugliese S; Mari Jde J
    Am J Med Genet; 1996 Apr; 67(2):238. PubMed ID: 8723058
    [No Abstract]   [Full Text] [Related]  

  • 24. Severe hypotension associated with concurrent clonidine and antipsychotic medication.
    Fruncillo RJ; Gibbons WJ; Vlasses PH; Ferguson RK
    Am J Psychiatry; 1985 Feb; 142(2):274. PubMed ID: 2857531
    [No Abstract]   [Full Text] [Related]  

  • 25. Thrombocytopenia associated with chlorpromazine, haloperidol and thiothixene: a case report.
    Balon R; Berchou R; Zethelius M
    Can J Psychiatry; 1987 Mar; 32(2):149-50. PubMed ID: 3567823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lithium and haloperidol treatments differently affect the mononuclear leukocyte Galphas protein levels in bipolar affective disorder.
    Karege F; Golaz J; Schwald M; Malafosse A
    Neuropsychobiology; 1999 May; 39(4):181-6. PubMed ID: 10343182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The medical-pharmacological management of acute psychoses.
    Young LD
    J S C Med Assoc; 1975 Sep; 71(9):274-81. PubMed ID: 241877
    [No Abstract]   [Full Text] [Related]  

  • 28. Reversible neurotoxicity with combined lithium-haloperidol administration.
    Keitner GI; Rahman S
    J Clin Psychopharmacol; 1984 Apr; 4(2):104-5. PubMed ID: 6423702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Incompatibility of lithium therapy with neuroleptics. a case report (author's transl)].
    Pühringer W; Kocher R; Gastpar M
    Nervenarzt; 1979 Feb; 50(2):124-7. PubMed ID: 34111
    [No Abstract]   [Full Text] [Related]  

  • 30. EEG observations in confirming neurotoxicity.
    Spring GK
    Am J Psychiatry; 1979 Aug; 136(8):1099-100. PubMed ID: 37751
    [No Abstract]   [Full Text] [Related]  

  • 31. [Persistent neurological syndrome after treatment with lithium salts. Toxicity of the lithium-neuroleptic combination?].
    Habib M; Khalil R; le Pensec-Bertrand D; Ali-Cherif A; Bongrand MC; Crevat A
    Rev Neurol (Paris); 1986; 142(1):61-4. PubMed ID: 2871617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicity resulting from lithium augmentation of antidepressant treatment in elderly patients.
    Austin LS; Arana GW; Melvin JA
    J Clin Psychiatry; 1990 Aug; 51(8):344-5. PubMed ID: 2380160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EEG observations during combined haloperidol-lithium treatment.
    Addy RO; Foliart RH; Saran AS; Schubert DS
    Biol Psychiatry; 1986 Feb; 21(2):170-6. PubMed ID: 3081054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for neuroleptic malignant syndrome.
    Akpaffiong MJ
    J Natl Med Assoc; 1992 Sep; 84(9):800-2. PubMed ID: 1404479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. To the incompatibility of haloperidol with lithium salts.
    Marhold J; Zimanová J; Lachman M; Král J; Vojtĕchovský M
    Act Nerv Super (Praha); 1974 Aug; 16(3):199-200. PubMed ID: 4420744
    [No Abstract]   [Full Text] [Related]  

  • 36. [Lasting neurological damage with therapeutic plasma lithium levels].
    van den Broek WW; van Hulst AM; Klompenhouwer JL; Moleman P
    Ned Tijdschr Geneeskd; 1988 Nov; 132(45):2063-6. PubMed ID: 2903456
    [No Abstract]   [Full Text] [Related]  

  • 37. Severe granulocytopenia secondary to chlorpromazine despite concurrent lithium treatment: a case report.
    Yen CF; Chong MY; Kuo MC; Chang CS
    Kaohsiung J Med Sci; 1997 Oct; 13(10):635-8. PubMed ID: 9385781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lithium-neuroleptic neurotoxicity is dose dependent.
    Miller F; Menninger J
    J Clin Psychopharmacol; 1987 Apr; 7(2):89-91. PubMed ID: 2884238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delirium and persistent dyskinesia induced by a lithium-neuroleptic interaction.
    Normann C; Brandt C; Berger M; Walden J
    Pharmacopsychiatry; 1998 Sep; 31(5):201-4. PubMed ID: 9832353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guidelines for combination of lithium and neuroleptics.
    Campbell HD; Moffic HS
    Tex Med; 1983 Sep; 79(9):60-2. PubMed ID: 6138872
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.